Decorative image

Early Access to Medicines Scheme

The Early Access to Medicines Scheme (EAMS) aims to make promising new medicines available to patients sooner. It was set up in 2015 and is run by the Medicines and Healthcare Products Regulatory Agency (MHRA).

About the Early Access to Medicines Scheme

Read about what the Early Access to Medicines Scheme (EAMS) is and how the EAMS makes decisions.

Safety measures and the Early Access to Medicines Scheme

Find out about safety measures, drugs that are available and what to do if you want an EAMS drug. 

Last reviewed: 
11 Aug 2017

Information and help